Follow the people · Insider
Eric D. Shaff
Eric D. Shaff files insider transactions with the SEC as a ceo and president of Seres Therapeutics (MCRB). We hold 3 disclosed purchases and sales filed since 29 June 2015, 1 of them in the last 90 days.
- Files forMCRB
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 June 2015 — 17 August 2026CEO and President · Seres Therapeutics (MCRB)99 Form 4 lines · source: SEC Form 4
- Filed 24 June 2021 — 11 August 2023Director · Sigilon Therapeutics (SGTX)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
104 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 722 shares of Seres TherapeuticsSEC Form 418 August 2026Common Stock · traded 15 August 2026 · filed 18 August 2026
- ▼ sold on the open market 263 shares of Seres TherapeuticsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- exercised options over 390 shares of Seres Therapeutics (a derivative holding)SEC Form 418 August 2026Restricted Stock Units · traded 15 August 2026 · filed 18 August 2026
- exercised options over 332 shares of Seres Therapeutics (a derivative holding)SEC Form 418 August 2026Restricted Stock Units · traded 15 August 2026 · filed 18 August 2026
- was granted 6,500 shares of Seres Therapeutics (a derivative holding)SEC Form 410 July 2026Stock Option (right to buy) · traded 8 July 2026 · filed 10 July 2026
- exercised options over 722 shares of Seres TherapeuticsSEC Form 419 May 2026Common Stock · traded 15 May 2026 · filed 19 May 2026
- ▼ sold on the open market 259 shares of Seres TherapeuticsSEC Form 419 May 2026Common Stock · traded 18 May 2026 · filed 19 May 2026
- exercised options over 391 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2026Restricted Stock Units · traded 15 May 2026 · filed 19 May 2026
- exercised options over 331 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2026Restricted Stock Units · traded 15 May 2026 · filed 19 May 2026
- exercised options over 723 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- ▼ sold on the open market 259 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- exercised options over 391 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 391 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 333 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 333 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 723 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- ▼ sold on the open market 259 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- exercised options over 390 shares of Seres Therapeutics (a derivative holding)SEC Form 418 November 2025Restricted Stock Units · traded 15 November 2025 · filed 18 November 2025
- exercised options over 331 shares of Seres Therapeutics (a derivative holding)SEC Form 418 November 2025Restricted Stock Units · traded 15 November 2025 · filed 18 November 2025
- exercised options over 390 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- exercised options over 331 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- ▼ sold on the open market 217 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- exercised options over 391 shares of Seres Therapeutics (a derivative holding)SEC Form 419 August 2025Restricted Stock Units · traded 15 August 2025 · filed 19 August 2025
- exercised options over 333 shares of Seres Therapeutics (a derivative holding)SEC Form 419 August 2025Restricted Stock Units · traded 15 August 2025 · filed 19 August 2025
- exercised options over 391 shares of Seres TherapeuticsSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- exercised options over 333 shares of Seres TherapeuticsSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- ▼ sold on the open market 217 shares of Seres TherapeuticsSEC Form 419 August 2025Common Stock · traded 18 August 2025 · filed 19 August 2025
- exercised options over 390 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2025Restricted Stock Units · traded 15 May 2025 · filed 19 May 2025
- exercised options over 331 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2025Restricted Stock Units · traded 15 May 2025 · filed 19 May 2025
- exercised options over 390 shares of Seres TherapeuticsSEC Form 419 May 2025Common Stock · traded 15 May 2025 · filed 19 May 2025
- exercised options over 331 shares of Seres TherapeuticsSEC Form 419 May 2025Common Stock · traded 15 May 2025 · filed 19 May 2025
- ▼ sold on the open market 220 shares of Seres TherapeuticsSEC Form 419 May 2025Common Stock · traded 16 May 2025 · filed 19 May 2025
- exercised options over 7,813 shares of Seres Therapeutics (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 15 February 2025 · filed 19 February 2025
- exercised options over 26,563 shares of Seres Therapeutics (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 15 February 2025 · filed 19 February 2025
- exercised options over 7,813 shares of Seres TherapeuticsSEC Form 419 February 2025Common Stock · traded 15 February 2025 · filed 19 February 2025
- exercised options over 26,563 shares of Seres TherapeuticsSEC Form 419 February 2025Common Stock · traded 15 February 2025 · filed 19 February 2025
- ▼ sold on the open market 12,726 shares of Seres TherapeuticsSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- was granted 1,950,000 shares of Seres Therapeutics (a derivative holding)SEC Form 411 February 2025Stock Option (Right to Buy) · traded 7 February 2025 · filed 11 February 2025
- exercised options over 7,812 shares of Seres Therapeutics (a derivative holding)SEC Form 419 November 2024Restricted Stock Units · traded 15 November 2024 · filed 19 November 2024
- exercised options over 7,812 shares of Seres TherapeuticsSEC Form 419 November 2024Common Stock · traded 15 November 2024 · filed 19 November 2024
- ▼ sold on the open market 2,505 shares of Seres TherapeuticsSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- exercised options over 27,837 shares of Seres Therapeutics (a derivative holding)SEC Form 429 October 2024Restricted Stock Units · traded 27 October 2024 · filed 29 October 2024
- exercised options over 27,837 shares of Seres TherapeuticsSEC Form 429 October 2024Common Stock · traded 27 October 2024 · filed 29 October 2024
- ▼ sold on the open market 8,748 shares of Seres TherapeuticsSEC Form 429 October 2024Common Stock · traded 28 October 2024 · filed 29 October 2024
- exercised options over 7,813 shares of Seres Therapeutics (a derivative holding)SEC Form 419 August 2024Restricted Stock Units · traded 15 August 2024 · filed 19 August 2024
- exercised options over 7,813 shares of Seres TherapeuticsSEC Form 419 August 2024Common Stock · traded 15 August 2024 · filed 19 August 2024
- ▼ sold on the open market 2,518 shares of Seres TherapeuticsSEC Form 419 August 2024Common Stock · traded 16 August 2024 · filed 19 August 2024
- exercised options over 7,812 shares of Seres Therapeutics (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 15 May 2024 · filed 17 May 2024
- exercised options over 7,812 shares of Seres TherapeuticsSEC Form 417 May 2024Common Stock · traded 15 May 2024 · filed 17 May 2024
- ▼ sold on the open market 2,435 shares of Seres TherapeuticsSEC Form 417 May 2024Common Stock · traded 15 May 2024 · filed 17 May 2024
- was granted 637,500 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Stock Option (Right to Buy) · traded 14 February 2024 · filed 16 February 2024
- was granted 822,580 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Stock Option (Right to Buy) · traded 14 February 2024 · filed 16 February 2024
- was granted 106,250 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 14 February 2024 · filed 16 February 2024
- exercised options over 31,250 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 15 February 2024 · filed 16 February 2024
- exercised options over 31,250 shares of Seres TherapeuticsSEC Form 416 February 2024Common Stock · traded 15 February 2024 · filed 16 February 2024
- ▼ sold on the open market 11,549 shares of Seres TherapeuticsSEC Form 416 February 2024Common Stock · traded 16 February 2024 · filed 16 February 2024
- was granted 55,675 shares of Seres Therapeutics (a derivative holding)SEC Form 431 October 2023Restricted Stock Units · traded 27 April 2023 · filed 31 October 2023
- exercised options over 27,838 shares of Seres Therapeutics (a derivative holding)SEC Form 431 October 2023Restricted Stock Units · traded 27 October 2023 · filed 31 October 2023
- exercised options over 27,838 shares of Seres TherapeuticsSEC Form 431 October 2023Common Stock · traded 27 October 2023 · filed 31 October 2023
- ▼ sold on the open market 8,552 shares of Seres TherapeuticsSEC Form 431 October 2023Common Stock · traded 30 October 2023 · filed 31 October 2023
- returned to the issuer 683 shares of Sigilon Therapeutics (a derivative holding)SEC Form 411 August 2023Stock Option (Right to Buy) · traded 11 August 2023 · filed 11 August 2023
- returned to the issuer 683 shares of Sigilon Therapeutics (a derivative holding)SEC Form 411 August 2023Stock Option (Right to Buy) · traded 11 August 2023 · filed 11 August 2023
- was granted 8,888 shares of Sigilon Therapeutics (a derivative holding)SEC Form 422 May 2023Stock Option (Right to Buy) · traded 19 May 2023 · filed 22 May 2023
- was granted 125,000 shares of Seres Therapeutics (a derivative holding)SEC Form 47 February 2023Restricted Stock Units · traded 3 February 2023 · filed 7 February 2023
- was granted 250,000 shares of Seres Therapeutics (a derivative holding)SEC Form 47 February 2023Stock Option (Right to Buy) · traded 3 February 2023 · filed 7 February 2023
- was granted 63,492 shares of Seres TherapeuticsSEC Form 46 July 2022COMMON STOCK · traded 5 July 2022 · filed 6 July 2022
- was granted 8,888 shares of Sigilon Therapeutics (a derivative holding)SEC Form 427 May 2022Stock Option (Right to Buy) · traded 26 May 2022 · filed 27 May 2022
- was granted 500,000 shares of Seres Therapeutics (a derivative holding)SEC Form 48 February 2022Stock Option (Right to Buy) · traded 4 February 2022 · filed 8 February 2022
- was granted 8,888 shares of Sigilon Therapeutics (a derivative holding)SEC Form 428 June 2021Stock Option (Right to Buy) · traded 24 June 2021 · filed 28 June 2021
- was granted 350,000 shares of Seres Therapeutics (a derivative holding)SEC Form 48 February 2021Stock Option (Right to Buy) · traded 4 February 2021 · filed 8 February 2021
- was granted 1,000,000 shares of Seres Therapeutics (a derivative holding)SEC Form 431 January 2020STOCK OPTION (RIGHT TO BUY) · traded 29 January 2020 · filed 31 January 2020
- exercised options over 20,000 shares of Seres Therapeutics (a derivative holding)SEC Form 428 January 2020RESTRICTED STOCK UNITS · traded 26 January 2020 · filed 28 January 2020
- exercised options over 20,000 shares of Seres TherapeuticsSEC Form 428 January 2020COMMON STOCK · traded 26 January 2020 · filed 28 January 2020
- was granted 275,000 shares of Seres Therapeutics (a derivative holding)SEC Form 429 January 2019STOCK OPTION (RIGHT TO BUY) · traded 25 January 2019 · filed 29 January 2019
- exercised options over 12,000 shares of Seres Therapeutics (a derivative holding)SEC Form 429 January 2019RESTRICTED STOCK UNITS · traded 26 January 2019 · filed 29 January 2019
- exercised options over 12,000 shares of Seres TherapeuticsSEC Form 429 January 2019COMMON STOCK · traded 26 January 2019 · filed 29 January 2019
- ▼ sold on the open market 4,378 shares of Seres TherapeuticsSEC Form 429 January 2019COMMON STOCK · traded 28 January 2019 · filed 29 January 2019
- exercised options over 8,000 shares of Seres TherapeuticsSEC Form 430 January 2018COMMON STOCK · traded 26 January 2018 · filed 30 January 2018
- ▼ sold on the open market 2,780 shares of Seres TherapeuticsSEC Form 430 January 2018COMMON STOCK · traded 26 January 2018 · filed 30 January 2018
- exercised options over 8,000 shares of Seres Therapeutics (a derivative holding)SEC Form 430 January 2018RESTRICTED STOCK UNITS · traded 26 January 2018 · filed 30 January 2018
- was granted 120,000 shares of Seres Therapeutics (a derivative holding)SEC Form 430 January 2018STOCK OPTION (RIGHT TO BUY) · traded 30 January 2018 · filed 30 January 2018
- was granted 105,000 shares of Seres Therapeutics (a derivative holding)SEC Form 427 January 2017Stock Option (right to buy) · traded 26 January 2017 · filed 27 January 2017
- was granted 40,000 shares of Seres Therapeutics (a derivative holding)SEC Form 427 January 2017Restricted Stock Units · traded 26 January 2017 · filed 27 January 2017
- exercised options over 4,533 shares of Seres TherapeuticsSEC Form 430 June 2016Common Stock · traded 30 June 2016 · filed 30 June 2016
- ▼ sold on the open market 4,533 shares of Seres TherapeuticsSEC Form 430 June 2016Common Stock · traded 30 June 2016 · filed 30 June 2016
- exercised options over 4,533 shares of Seres Therapeutics (a derivative holding)SEC Form 430 June 2016Stock Option (right to buy) · traded 30 June 2016 · filed 30 June 2016
- exercised options over 3,334 shares of Seres TherapeuticsSEC Form 429 June 2016Common Stock · traded 27 June 2016 · filed 29 June 2016
- ▼ sold on the open market 3,334 shares of Seres TherapeuticsSEC Form 429 June 2016Common Stock · traded 27 June 2016 · filed 29 June 2016
- exercised options over 1,667 shares of Seres TherapeuticsSEC Form 429 June 2016Common Stock · traded 28 June 2016 · filed 29 June 2016
- ▼ sold on the open market 1,667 shares of Seres TherapeuticsSEC Form 429 June 2016Common Stock · traded 28 June 2016 · filed 29 June 2016
- exercised options over 3,334 shares of Seres Therapeutics (a derivative holding)SEC Form 429 June 2016Stock Option (right to buy) · traded 27 June 2016 · filed 29 June 2016
- exercised options over 1,667 shares of Seres Therapeutics (a derivative holding)SEC Form 429 June 2016Stock Option (right to buy) · traded 28 June 2016 · filed 29 June 2016
- exercised options over 6,568 shares of Seres TherapeuticsSEC Form 46 April 2016Common Stock · traded 4 April 2016 · filed 6 April 2016
- ▼ sold on the open market 6,568 shares of Seres TherapeuticsSEC Form 46 April 2016Common Stock · traded 4 April 2016 · filed 6 April 2016
- exercised options over 6,568 shares of Seres Therapeutics (a derivative holding)SEC Form 46 April 2016Stock Option (right to buy) · traded 4 April 2016 · filed 6 April 2016
- exercised options over 7,663 shares of Seres TherapeuticsSEC Form 44 April 2016Common Stock · traded 31 March 2016 · filed 4 April 2016
- ▼ sold on the open market 1,095 shares of Seres TherapeuticsSEC Form 44 April 2016Common Stock · traded 31 March 2016 · filed 4 April 2016
- ▼ sold on the open market 6,568 shares of Seres TherapeuticsSEC Form 44 April 2016Common Stock · traded 31 March 2016 · filed 4 April 2016
- exercised options over 7,663 shares of Seres Therapeutics (a derivative holding)SEC Form 44 April 2016Stock Option (right to buy) · traded 31 March 2016 · filed 4 April 2016
- exercised options over 5,473 shares of Seres TherapeuticsSEC Form 429 March 2016Common Stock · traded 28 March 2016 · filed 29 March 2016
- ▼ sold on the open market 5,473 shares of Seres TherapeuticsSEC Form 429 March 2016Common Stock · traded 28 March 2016 · filed 29 March 2016
- exercised options over 5,473 shares of Seres Therapeutics (a derivative holding)SEC Form 429 March 2016Stock Option (right to buy) · traded 28 March 2016 · filed 29 March 2016
- was granted 78,500 shares of Seres Therapeutics (a derivative holding)SEC Form 43 February 2016Stock Option (Right to Buy) · traded 1 February 2016 · filed 3 February 2016
- was granted 100,000 shares of Seres Therapeutics (a derivative holding)SEC Form 429 June 2015Stock Option (right to buy) · traded 25 June 2015 · filed 29 June 2015
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.